The Institute of Cancer Research attracts the very best science graduates and clinicians to carry out cutting-edge research and make the discoveries that defeat cancer. Our students enjoy working in a high-tech and collaborative environment, in which their research can be translated into direct benefits for patients.
Irene Matucci is carrying out a PhD in the Molecular Addictions Team, studying the interplay between metabolism and cancer cell signalling with a focus on glioblastoma, intestinal and breast cancer. She is the President of the ICR’s Student Union.
Joshua Freedman is a third-year PhD student in the Division of Radiotherapy and Imaging. His research is helping to develop the MR Linac, a revolutionary new type of radiotherapy machine which is currently being tested for the first time on patients.
Laura is a Cancer Research UK-funded PhD student in the Division of Structural Biology, working to understand how deregulation of a protein known as RNA polymerase III can cause cancer.
Daniel Lam’s PhD project in the Therapeutic Ultrasound team is working towards the development of a new software programme which will help clinicians to determine, from a standard referral image, whether a patient is treatable with ultrasound.
Stephen Turnock is doing his PhD in the Preclinical Molecular Imaging team, looking at imaging biomarkers that can be used for monitoring treatment response in neuroblastoma.
Somaieh Hedayat is working towards a PhD on how the tissue microenvironment can affect the response of metastatic colorectal cancer cells to antiangiogenic therapies.
Oliver Pickford Scienti is doing a PhD in the Multimodal Molecular Imaging Team which involves using gold nanoparticles to help improve the effectiveness of radiotherapy.
David McBay's PhD project aims to understand the molecular mechanisms that determine the effectiveness of fractionated radiotherapy.